Directors Deals 

Saga directors buy on weakness

Saga directors buy on weakness

In early April, Saga (SAGA) dramatically overhauled its growth strategy as it sought to address the continued commoditisation of the insurance market. It cut its final dividend to just 1p, a sixth of the previous year’s payment, while taking a £310m impairment and warning of profitability “significantly below” previous years. This led to a sharp drop in the share price, closing the day down 37 per cent on the previous day’s closing price.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now